DERM(DERM)
DERM
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $83M | $138M | $198M | $225M | $240M |
| Low | $82M | $133M | $187M | $211M | $226M |
| High | $84M | $142M | $211M | $239M | $256M |
| EBITDA Avg | $-17M | $-28M | $-40M | $-45M | $-49M |
| Low | $-17M | $-29M | $-43M | $-48M | $-52M |
| High | $-17M | $-27M | $-38M | $-43M | $-46M |
| EBIT Avg | $-21M | $-36M | $-51M | $-58M | $-62M |
| Low | $-22M | $-37M | $-55M | $-62M | $-66M |
| High | $-21M | $-35M | $-48M | $-55M | $-58M |
| Net Income Avg | $1M | $28M | $57M | $35M | $42M |
| Low | $-442,324 | $20M | $42M | $32M | $38M |
| High | $4M | $31M | $68M | $38M | $45M |
| EPS Avg | $0.07 | $1.04 | $2.25 | $1.42 | $1.70 |
| Low | $-0.02 | $0.81 | $1.73 | $1.31 | $1.57 |
| High | $0.14 | $1.26 | $2.76 | $1.53 | $1.84 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 2 / 2 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $22M | $26M | $24M | $28M | $34M | $35M |
| Low | $22M | $25M | $24M | $27M | $33M | $34M |
| High | $23M | $27M | $25M | $28M | $35M | $36M |
| EBITDA Avg | $-5M | $-5M | $-5M | $-6M | $-7M | $-7M |
| Low | $-5M | $-5M | $-5M | $-6M | $-7M | $-7M |
| High | $-4M | $-5M | $-5M | $-5M | $-7M | $-7M |
| EBIT Avg | $-6M | $-7M | $-6M | $-7M | $-9M | $-9M |
| Low | $-6M | $-7M | $-6M | $-7M | $-9M | $-9M |
| High | $-6M | $-7M | $-6M | $-7M | $-9M | $-9M |
| Net Income Avg | $1M | $3M | $546,100 | $2M | $5M | $5M |
| Low | $477,838 | $3M | $530,304 | $2M | $5M | $5M |
| High | $2M | $3M | $569,596 | $2M | $5M | $5M |
| EPS Avg | $0.05 | $0.10 | $0.02 | $0.07 | $0.18 | $0.18 |
| Low | $0.02 | $0.09 | $0.02 | $0.07 | $0.17 | $0.17 |
| High | $0.08 | $0.10 | $0.02 | $0.07 | $0.19 | $0.19 |
| Analysts (Rev / EPS) | 3 / 3 | 2 / 1 | 1 / 1 | 2 / 1 | 2 / 1 | 1 / 1 |